Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JAYNIER MOYA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1124288980
CMS profile
278302
Location
PEMBROKE PINES, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$128.50

2 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $128.50 2

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $128.50 2

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JAYNIER MOYA

NPI 1124288980 · CMS profile ID 278302

Allopathic & Osteopathic Physicians / Internal Medicine

PEMBROKE PINES, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1124288980?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JAYNIER MOYA, NPI 1124288980, CMS profile ID 278302. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1124288980?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). JAYNIER MOYA, NPI 1124288980, CMS profile ID 278302. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1124288980?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
JAYNIER MOYA, NPI 1124288980, CMS profile ID 278302, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1124288980?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

2 matching records · $128.50 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 2 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–2 of 2.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $7.3510/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945136427 CMS
GlaxoSmithKline, LLC. $121.1510/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945136429 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $128.50 2
PY2023 $1,741.44 2
PY2025 $15.30 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $3,567,242.14 108
PY2024 Recipient $1,161.49 6
PY2024 Principal investigator $5,059,140.87 296
PY2023 Recipient $2,506.25 1
PY2023 Principal investigator $14,127,127.37 743
PY2022 Recipient $24,618.00 1
PY2022 Principal investigator $15,001,316.81 131
PY2021 Principal investigator $6,255,399.36 48
PY2020 Principal investigator $653,923.11 62
PY2019 Principal investigator $748,551.83 218

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

218 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $3,674.14 12/21/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671676879
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143463
Principal investigator 1 AKEBIA THERAPEUTICS INC $991.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143465
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143467
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143469
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143471
Principal investigator 1 AKEBIA THERAPEUTICS INC $965.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143473
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143475
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143477
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143479
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143481
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143483
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143485
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 12/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143487
Principal investigator 1 AKEBIA THERAPEUTICS INC $965.00 12/13/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143459
Principal investigator 1 AKEBIA THERAPEUTICS INC $859.00 12/13/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143461
Principal investigator 1 PFIZER INC. $1,128.15 12/12/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671672291
Principal investigator 1 Ferring International Pharmascience Center US $1,029.60 12/06/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A Randomised, Double-blind, Placebo-controlled, Response-adaptive Dose-finding Trial Investigating the Efficacy, Safety and Tolerability of Oral Doses of FE 201836, With Desmopressin Orally Disintegrating Tablet as a Benchmark, During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Adults No dispute reported 06/30/2026 655228611
Principal investigator 1 AKEBIA THERAPEUTICS INC $189.00 12/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143449
Principal investigator 1 AKEBIA THERAPEUTICS INC $189.00 12/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143451
Principal investigator 1 AKEBIA THERAPEUTICS INC $151.00 12/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143453
Principal investigator 1 AKEBIA THERAPEUTICS INC $151.00 12/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143455
Principal investigator 1 AKEBIA THERAPEUTICS INC $126.00 12/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143457
Principal investigator 1 PFIZER INC. $55,794.22 12/05/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671677333
Principal investigator 1 SANOFI US SERVICES INC. $4,785.00 12/05/2019 Non-covered Recipient Entity
Pines Care Center
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to Metformin in Patients With Type 2 Diabetes Mellitus Who No dispute reported 06/30/2026 691608151
Principal investigator 1 AKEBIA THERAPEUTICS INC $248.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143429
Principal investigator 1 AKEBIA THERAPEUTICS INC $931.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143431
Principal investigator 1 AKEBIA THERAPEUTICS INC $931.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143433
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143435
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143437
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143439
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143441
Principal investigator 1 AKEBIA THERAPEUTICS INC $248.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143443
Principal investigator 1 AKEBIA THERAPEUTICS INC $248.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143445
Principal investigator 1 AKEBIA THERAPEUTICS INC $248.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143447
Principal investigator 1 Ferring International Pharmascience Center US $6,700.00 12/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A Randomised, Double-blind, Placebo-controlled, Response-adaptive Dose-finding Trial Investigating the Efficacy, Safety and Tolerability of Oral Doses of FE 201836, With Desmopressin Orally Disintegrating Tablet as a Benchmark, During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Adults No dispute reported 06/30/2026 655228565
Principal investigator 1 SANOFI US SERVICES INC. $1,746.00 11/25/2019 Non-covered Recipient Entity
Pines Care Center
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to Metformin in Patients With Type 2 Diabetes Mellitus Who No dispute reported 06/30/2026 691607119
Principal investigator 1 SANOFI US SERVICES INC. $8,400.00 11/25/2019 Non-covered Recipient Entity
Pines Care Center
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to Metformin in Patients With Type 2 Diabetes Mellitus Who No dispute reported 06/30/2026 691607269
Principal investigator 1 SANOFI US SERVICES INC. $2,250.00 11/25/2019 Non-covered Recipient Entity
Pines Care Center
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to Metformin in Patients With Type 2 Diabetes Mellitus Who No dispute reported 06/30/2026 691607273
Principal investigator 1 SANOFI US SERVICES INC. $2,100.00 11/25/2019 Non-covered Recipient Entity
Pines Care Center
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to Metformin in Patients With Type 2 Diabetes Mellitus Who No dispute reported 06/30/2026 691607278
Principal investigator 1 PFIZER INC. $16,246.45 11/23/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671678127
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/22/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143423
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/22/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143425
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/22/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143427
Principal investigator 1 PFIZER INC. $451.26 11/20/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671669399
Principal investigator 1 PFIZER INC. $3,218.13 11/13/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671668723
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143363
Principal investigator 1 AKEBIA THERAPEUTICS INC $965.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143365
Principal investigator 1 AKEBIA THERAPEUTICS INC $842.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143367
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143369
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143371
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143373
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143375
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143377
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143379
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143381
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143383
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143385
Principal investigator 1 AKEBIA THERAPEUTICS INC $965.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143387
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143389
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143391
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143393
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143395
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143397
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143399
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143401
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143403
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143405
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143407
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143409
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143411
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143413
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143415
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143417
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143419
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 11/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143421
Principal investigator 1 PFIZER INC. $19,812.50 11/02/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671677017
Principal investigator 1 PFIZER INC. $13,878.31 10/23/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671668687
Principal investigator 1 PFIZER INC. $2,398.77 10/23/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671672339
Principal investigator 1 PFIZER INC. $3,738.25 10/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671672161
Principal investigator 1 PFIZER INC. $13,588.09 10/04/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671676801
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/02/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143351
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/02/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143353
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/02/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143355
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/02/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143357
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/02/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143359
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/02/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143361
Principal investigator 1 Ferring International Pharmascience Center US $7,165.80 10/02/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A Randomised, Double-blind, Placebo-controlled, Response-adaptive Dose-finding Trial Investigating the Efficacy, Safety and Tolerability of Oral Doses of FE 201836, With Desmopressin Orally Disintegrating Tablet as a Benchmark, During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Adults No dispute reported 06/30/2026 655228291
Principal investigator 1 PFIZER INC. $2,762.12 10/02/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671671893
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143293
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,207.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143295
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143297
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143299
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143301
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143303
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143305
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143307
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143309
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143311
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143313
Principal investigator 1 AKEBIA THERAPEUTICS INC $842.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143315
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,207.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143317
Principal investigator 1 AKEBIA THERAPEUTICS INC $842.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143319
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143321
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143323
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143325
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143327
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143329
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143331
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143333
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143335
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,076.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143337
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,076.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143339
Principal investigator 1 AKEBIA THERAPEUTICS INC $965.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143341
Principal investigator 1 AKEBIA THERAPEUTICS INC $965.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143343
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143345
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143347
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 10/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143349
Principal investigator 1 SANOFI US SERVICES INC. $22,775.00 09/30/2019 Non-covered Recipient Entity
PINES CARE MEDICAL CENTER, LLC
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691570607
Principal investigator 1 PFIZER INC. $13,016.92 09/20/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671672519
Principal investigator 1 PFIZER INC. $860.94 09/18/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671677339
Principal investigator 1 PFIZER INC. $5,455.38 09/11/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671679203
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,207.00 09/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143281
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,076.00 09/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143283
Principal investigator 1 AKEBIA THERAPEUTICS INC $965.00 09/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143285
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 09/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143287
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 09/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143289
Principal investigator 1 AKEBIA THERAPEUTICS INC $842.00 09/05/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143291
Principal investigator 1 PFIZER INC. $8,215.83 08/28/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671671085
Principal investigator 1 PFIZER INC. $6,201.13 08/28/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671679243
Principal investigator 1 Ferring International Pharmascience Center US $26,463.60 08/26/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A Randomised, Double-blind, Placebo-controlled, Response-adaptive Dose-finding Trial Investigating the Efficacy, Safety and Tolerability of Oral Doses of FE 201836, With Desmopressin Orally Disintegrating Tablet as a Benchmark, During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Adults No dispute reported 06/30/2026 655228009
Principal investigator 1 Ferring International Pharmascience Center US $4,188.60 08/23/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A Randomised, Double-blind, Placebo-controlled, Response-adaptive Dose-finding Trial Investigating the Efficacy, Safety and Tolerability of Oral Doses of FE 201836, With Desmopressin Orally Disintegrating Tablet as a Benchmark, During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Adults No dispute reported 06/30/2026 655227969
Principal investigator 1 AKEBIA THERAPEUTICS INC $965.00 08/20/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143275
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 08/20/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143277
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 08/20/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143279
Principal investigator 1 PFIZER INC. $14,143.86 08/20/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671672169
Principal investigator 1 PFIZER INC. $12,328.65 08/14/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671678455
Principal investigator 1 PFIZER INC. $11,612.08 08/06/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671669269
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 08/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143271
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 08/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143273
Principal investigator 1 PFIZER INC. $5,340.19 07/24/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671642779
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 07/22/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143267
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 07/22/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143269
Principal investigator 1 PFIZER INC. $3,667.97 07/18/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671677571
Principal investigator 1 PFIZER INC. $225.63 07/17/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671642807
Principal investigator 1 PFIZER INC. $4,251.48 07/10/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671673679
Principal investigator 1 AKEBIA THERAPEUTICS INC $842.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143239
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,207.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143241
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143243
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143245
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143247
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143249
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,076.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143251
Principal investigator 1 AKEBIA THERAPEUTICS INC $965.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143253
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143255
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143257
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143259
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143261
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143263
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 07/09/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143265
Principal investigator 1 PFIZER INC. $7,015.74 07/02/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671642809
Principal investigator 1 PFIZER INC. $2,509.21 06/26/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671642811
Principal investigator 1 SANOFI US SERVICES INC. $37,043.00 06/25/2019 Non-covered Recipient Entity
PINES CARE MEDICAL CENTER, LLC
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691557453
Principal investigator 1 PFIZER INC. $7,931.78 06/22/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671642777
Principal investigator 1 PFIZER INC. $9,649.64 05/29/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671623813
Principal investigator 1 PFIZER INC. $1,905.93 05/22/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671623831
Principal investigator 1 PFIZER INC. $5,192.92 05/15/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671627889
Principal investigator 1 PFIZER INC. $2,129.20 05/08/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671623809
Principal investigator 1 PFIZER INC. $4,500.00 05/08/2019 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671623811
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 05/06/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143229
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 05/06/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143231
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/06/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143233
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/06/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143235
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/06/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143237
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143175
Principal investigator 1 AKEBIA THERAPEUTICS INC $965.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143177
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143179
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143181
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143183
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143185
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143187
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143189
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143191
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143193
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143195
Principal investigator 1 AKEBIA THERAPEUTICS INC $820.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143197
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143199
Principal investigator 1 AKEBIA THERAPEUTICS INC $820.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143201
Principal investigator 1 AKEBIA THERAPEUTICS INC $820.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143203
Principal investigator 1 AKEBIA THERAPEUTICS INC $820.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143205
Principal investigator 1 AKEBIA THERAPEUTICS INC $820.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143207
Principal investigator 1 AKEBIA THERAPEUTICS INC $820.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143209
Principal investigator 1 AKEBIA THERAPEUTICS INC $820.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143211
Principal investigator 1 AKEBIA THERAPEUTICS INC $820.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143213
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143215
Principal investigator 1 AKEBIA THERAPEUTICS INC $868.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143217
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143219
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143221
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143223
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143225
Principal investigator 1 AKEBIA THERAPEUTICS INC $825.00 05/03/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 707143227
Principal investigator 1 PFIZER INC. $13,541.04 05/01/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671623833
Principal investigator 1 PFIZER INC. $17,567.85 04/10/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671628313
Principal investigator 1 PFIZER INC. $8,996.51 03/27/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671628271
Principal investigator 1 SANOFI US SERVICES INC. $60,590.00 03/21/2019 Non-covered Recipient Entity
PINES CARE MEDICAL CENTER, LLC
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691545817
Principal investigator 1 PFIZER INC. $16,487.25 03/20/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671628275
Principal investigator 1 PFIZER INC. $5,365.12 03/13/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671628241
Principal investigator 1 PFIZER INC. $9,705.43 03/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671628273
Principal investigator 1 PFIZER INC. $6,755.70 02/20/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671616011
Principal investigator 1 PFIZER INC. $18,085.62 02/13/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671616661
Principal investigator 1 Boehringer Ingelheim b.v. $573.00 02/07/2019 Non-covered Recipient Entity
DIRECT HELPERS MEDCL CTR
CARMELINA No dispute reported 06/30/2026 703549895
Principal investigator 1 Boehringer Ingelheim b.v. $375.00 02/05/2019 Non-covered Recipient Entity
DIRECT HELPERS MEDCL CTR
CARMELINA No dispute reported 06/30/2026 703549893
Principal investigator 1 PFIZER INC. $10,074.72 02/04/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671616391
Principal investigator 1 AKEBIA THERAPEUTICS INC $203.62 01/24/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER, INC.
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143171
Principal investigator 1 AKEBIA THERAPEUTICS INC $2,434.05 01/24/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER, INC.
AKB-6548-CI-0015 No dispute reported 06/30/2026 707143173
Principal investigator 1 PFIZER INC. $36,698.54 01/16/2019 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 671616743
Principal investigator 1 AstraZeneca Pharmaceuticals LP $16,040.32 01/15/2019 Non-covered Recipient Entity
Elias Research Associates Llc
A Multinational Randomised Double Blind Placebo Controlled Trial to Evaluate the Effect of Ticagrelor 90 mg twice daily on the Incidence of Cardiovascular Death Myocardial Infarction or Stroke in Patients with Type 2 Diabetes No dispute reported 06/30/2026 684980073
Principal investigator 1 AbbVie, Inc. $7,301.59 01/11/2019 Non-covered Recipient Entity
Pines Care Research Center Inc
M11-352 No dispute reported 06/30/2026 647588159